Loading…
Based on limited metadata, NuCare Pharmaceuticals Inc. received an FDA Warning Letter on September 26, 2019, regarding its drug products. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the metadata provided.